Your session is about to expire
← Back to Search
Other
All-blood cardioplegia for Coronary Artery Disease (ABC Trial)
N/A
Waitlist Available
Led By Stacy O'Blenes, MD
Research Sponsored by Pam Trenholm
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 d
Awards & highlights
ABC Trial Summary
This trial is testing whether using all-blood or more diluted cardioplegia during cardiac surgery results in less blood transfusion or better cardiac function.
Eligible Conditions
- Coronary Artery Disease
- Valvular Heart Disease
ABC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 d
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 d
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood transfusion
Intra-op diastolic function
Secondary outcome measures
Duration of Ventilation
Fluid balance
Hgb - arrival ICU
+13 moreABC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Patients receive all-blood cardiolpegia for myocardial protection during surgery
Group II: ControlActive Control1 Intervention
Patients receive standard 4:1 cardioplegia for myocardial protection during cardiac surgery
Find a Location
Who is running the clinical trial?
Pam TrenholmLead Sponsor
Stacy OBlenesLead Sponsor
Stacy O'Blenes, MDPrincipal InvestigatorDalhousie University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger